vs
Side-by-side financial comparison of AMREP CORP. (AXR) and Electromed, Inc. (ELMD). Click either name above to swap in a different company.
Electromed, Inc. is the larger business by last-quarter revenue ($18.9M vs $14.6M, roughly 1.3× AMREP CORP.). AMREP CORP. runs the higher net margin — 21.6% vs 14.6%, a 7.0% gap on every dollar of revenue. On growth, AMREP CORP. posted the faster year-over-year revenue change (93.8% vs 16.3%). AMREP CORP. produced more free cash flow last quarter ($5.4M vs $2.4M). Over the past eight quarters, Electromed, Inc.'s revenue compounded faster (16.7% CAGR vs -13.6%).
AMREP Corporation is a real estate and media services company based in Princeton, New Jersey, in the United States. It was founded in 1961 as The American Realty and Petroleum Corporation.
Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.
AXR vs ELMD — Head-to-Head
Income Statement — Q3 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $14.6M | $18.9M |
| Net Profit | $3.1M | $2.8M |
| Gross Margin | — | 78.4% |
| Operating Margin | 20.6% | 19.2% |
| Net Margin | 21.6% | 14.6% |
| Revenue YoY | 93.8% | 16.3% |
| Net Profit YoY | 338.9% | 40.3% |
| EPS (diluted) | $0.58 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $14.6M | — | ||
| Q4 25 | $9.4M | $18.9M | ||
| Q3 25 | $17.9M | $16.9M | ||
| Q2 25 | $11.2M | $17.4M | ||
| Q1 25 | $7.5M | $15.7M | ||
| Q4 24 | $11.9M | $16.3M | ||
| Q3 24 | $19.1M | $14.7M | ||
| Q2 24 | $19.5M | $14.8M |
| Q1 26 | $3.1M | — | ||
| Q4 25 | $1.2M | $2.8M | ||
| Q3 25 | $4.7M | $2.1M | ||
| Q2 25 | $3.9M | $2.2M | ||
| Q1 25 | $717.0K | $1.9M | ||
| Q4 24 | $4.0M | $2.0M | ||
| Q3 24 | $4.1M | $1.5M | ||
| Q2 24 | $4.1M | $1.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 78.4% | ||
| Q3 25 | — | 78.1% | ||
| Q2 25 | — | 78.3% | ||
| Q1 25 | — | 78.0% | ||
| Q4 24 | — | 77.7% | ||
| Q3 24 | — | 78.3% | ||
| Q2 24 | — | 76.2% |
| Q1 26 | 20.6% | — | ||
| Q4 25 | 11.9% | 19.2% | ||
| Q3 25 | 34.4% | 15.8% | ||
| Q2 25 | 31.7% | 17.5% | ||
| Q1 25 | 5.7% | 13.6% | ||
| Q4 24 | 26.4% | 15.6% | ||
| Q3 24 | 26.1% | 13.2% | ||
| Q2 24 | 23.9% | 15.7% |
| Q1 26 | 21.6% | — | ||
| Q4 25 | 12.8% | 14.6% | ||
| Q3 25 | 26.3% | 12.6% | ||
| Q2 25 | 34.8% | 12.7% | ||
| Q1 25 | 9.5% | 12.1% | ||
| Q4 24 | 33.9% | 12.1% | ||
| Q3 24 | 21.3% | 10.0% | ||
| Q2 24 | 21.2% | 12.3% |
| Q1 26 | $0.58 | — | ||
| Q4 25 | $0.22 | $0.32 | ||
| Q3 25 | $0.87 | $0.25 | ||
| Q2 25 | $0.73 | $0.26 | ||
| Q1 25 | $0.13 | $0.21 | ||
| Q4 24 | $0.75 | $0.22 | ||
| Q3 24 | $0.76 | $0.16 | ||
| Q2 24 | $0.77 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $50.0M | $13.8M |
| Total DebtLower is stronger | $21.0K | — |
| Stockholders' EquityBook value | $139.4M | $45.4M |
| Total Assets | $143.9M | $54.9M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $50.0M | — | ||
| Q4 25 | $44.6M | $13.8M | ||
| Q3 25 | $48.9M | $14.1M | ||
| Q2 25 | $39.5M | $15.3M | ||
| Q1 25 | $36.9M | $15.2M | ||
| Q4 24 | $40.1M | $16.2M | ||
| Q3 24 | $40.4M | $13.9M | ||
| Q2 24 | $29.7M | $16.1M |
| Q1 26 | $21.0K | — | ||
| Q4 25 | $23.0K | — | ||
| Q3 25 | $25.0K | — | ||
| Q2 25 | $26.0K | — | ||
| Q1 25 | $29.0K | — | ||
| Q4 24 | $32.0K | — | ||
| Q3 24 | $34.0K | — | ||
| Q2 24 | $35.0K | — |
| Q1 26 | $139.4M | — | ||
| Q4 25 | $136.0M | $45.4M | ||
| Q3 25 | $134.7M | $44.7M | ||
| Q2 25 | $130.0M | $43.2M | ||
| Q1 25 | $126.0M | $43.9M | ||
| Q4 24 | $125.1M | $43.6M | ||
| Q3 24 | $122.2M | $41.5M | ||
| Q2 24 | $118.0M | $44.5M |
| Q1 26 | $143.9M | — | ||
| Q4 25 | $140.1M | $54.9M | ||
| Q3 25 | $140.7M | $53.6M | ||
| Q2 25 | $133.8M | $53.8M | ||
| Q1 25 | $128.9M | $52.5M | ||
| Q4 24 | $129.1M | $52.3M | ||
| Q3 24 | $127.0M | $48.9M | ||
| Q2 24 | $122.8M | $52.2M |
| Q1 26 | 0.00× | — | ||
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.4M | $3.0M |
| Free Cash FlowOCF − Capex | $5.4M | $2.4M |
| FCF MarginFCF / Revenue | 37.0% | 12.7% |
| Capex IntensityCapex / Revenue | 0.1% | 3.4% |
| Cash ConversionOCF / Net Profit | 1.72× | 1.10× |
| TTM Free Cash FlowTrailing 4 quarters | $20.2M | $7.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $5.4M | — | ||
| Q4 25 | $-4.3M | $3.0M | ||
| Q3 25 | $9.5M | $169.0K | ||
| Q2 25 | $10.2M | $3.9M | ||
| Q1 25 | $-3.2M | $2.1M | ||
| Q4 24 | $-182.0K | $3.2M | ||
| Q3 24 | $10.7M | $2.3M | ||
| Q2 24 | $10.7M | $4.5M |
| Q1 26 | $5.4M | — | ||
| Q4 25 | $-4.3M | $2.4M | ||
| Q3 25 | $9.5M | $-83.0K | ||
| Q2 25 | $9.7M | $3.7M | ||
| Q1 25 | $-3.3M | $1.9M | ||
| Q4 24 | $-268.0K | $2.9M | ||
| Q3 24 | $10.7M | $2.3M | ||
| Q2 24 | $10.3M | $4.5M |
| Q1 26 | 37.0% | — | ||
| Q4 25 | -45.9% | 12.7% | ||
| Q3 25 | 53.2% | -0.5% | ||
| Q2 25 | 86.4% | 21.4% | ||
| Q1 25 | -43.4% | 12.2% | ||
| Q4 24 | -2.3% | 18.0% | ||
| Q3 24 | 55.8% | 15.5% | ||
| Q2 24 | 52.5% | 30.1% |
| Q1 26 | 0.1% | — | ||
| Q4 25 | 0.6% | 3.4% | ||
| Q3 25 | 0.1% | 1.5% | ||
| Q2 25 | 5.2% | 0.8% | ||
| Q1 25 | 0.3% | 1.0% | ||
| Q4 24 | 0.7% | 1.4% | ||
| Q3 24 | 0.2% | 0.3% | ||
| Q2 24 | 2.3% | 0.1% |
| Q1 26 | 1.72× | — | ||
| Q4 25 | -3.54× | 1.10× | ||
| Q3 25 | 2.03× | 0.08× | ||
| Q2 25 | 2.63× | 1.75× | ||
| Q1 25 | -4.51× | 1.10× | ||
| Q4 24 | -0.05× | 1.60× | ||
| Q3 24 | 2.63× | 1.57× | ||
| Q2 24 | 2.59× | 2.46× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXR
Segment breakdown not available.
ELMD
| Homecare | $17.3M | 91% |
| Other | $1.6M | 9% |
